HuGE Literature Finder
Records
1
-
5
| GSTP1 as a potential predictive factor for adverse events associated with platinum-based antitumor agent-induced peripheral neuropathy. Oncology letters 2019 3 17 (3): 2897-2904. Katayanagi Sou, Katsumata Kenji, Mori Yasuharu, Narahara Katsunori, Shigoka Masatoshi, Matsudo Takaaki, Enomoto Masanori, Suda Takeshi, Ishizaki Tetsuo, Hisada Masayuki, Nagakawa Yuuichi, Tsuchida Akihi |
| Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma. Oncotarget 2017 12 8 (55): 93942-93956. Henriksen Stine Dam, Madsen Poul Henning, Larsen Anders Christian, Johansen Martin Berg, Pedersen Inge Søkilde, Krarup Henrik, Thorlacius-Ussing O |
| Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-institutional case-control study in Japan. Asian Pacific journal of cancer prevention : APJCP 2014 15 (1): 391-5. Yamada Ikuhiro, Matsuyama Masato, Ozaka Masato, Inoue Dai, Muramatsu Yusuke, Ishii Hiroshi, Junko Ueda, Ueno Makoto, Egawa Naoto, Nakao Haruhisa, Mori Mitsuru, Matsuo Keitaro, Nishiyama Takeshi, Ohkawa Shinichi, Hosono Satoyo, Wakai Kenji, Nakamura Kozue, Tamakoshi Akiko, Kuruma Sawako, Nojima Masanori, Takahashi Mami, Shimada Kazuaki, Yagyu Kiyoko, Kikuchi Shogo, Lin Yingso |
| Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. Cancer 2007 Mar 109 (5): 840-8. Jiao Li, Bondy Melissa L, Hassan Manal M, Chang David Z, Abbruzzese James L, Evans Douglas B, Smolensky Michael H, Li Dongh |
| The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population. Mutation research 0 680 (1-2): 78-81. Vrana D, Pikhart H, Mohelnikova-Duchonova B, Holcatova I, Strnad R, Slamova A, Schejbalova M, Ryska M, Susova S, Soucek |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: